Surgical management of oropharyngeal squamous cell carcinoma: Survival and functional outcomes

被引:43
作者
Kumar, Bhavna
Cipolla, Michael J.
Old, Matthew O.
Brown, Nicole V.
Kang, Stephen Y.
Dziegielewski, Peter T.
Durmus, Kasim
Ozer, Enver
Agrawal, Amit
Carrau, Ricardo L.
Schuller, David E.
Leon, Marino E.
Pan, Quintin
Kumar, Pawan
Wood, Valerie
Burgers, Jessica
Wakely, Paul E., Jr.
Teknos, Theodoros N. [1 ,2 ]
机构
[1] Ohio State Univ, Wexner Med Ctr, James Canc Hosp, Dept Otolaryngol Head & Neck Surg, 915 Olentangy River Rd,Suite 4000, Columbus, OH 43212 USA
[2] Ohio State Univ, Wexner Med Ctr, Solove Res Inst, 915 Olentangy River Rd,Suite 4000, Columbus, OH 43212 USA
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2016年 / 38卷
关键词
surgery oropharynx; oropharyngeal cancer; human papillomavirus; squamous cell carcinoma; transoral surgery; TRANSORAL ROBOTIC SURGERY; QUALITY-OF-LIFE; LOCALLY ADVANCED HEAD; PHASE-III TRIAL; HUMAN-PAPILLOMAVIRUS; NECK-CANCER; RADIATION-THERAPY; CONCOMITANT CHEMOTHERAPY; RANDOMIZED-TRIAL; CHEMORADIATION;
D O I
10.1002/hed.24319
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. The purpose of this study was to further define the impact of primary surgery in the management of oropharyngeal squamous cell carcinoma (SCC). Methods. Two hundred ninety-six patients with oropharyngeal SCC treated with primary surgery were included. Multivariable analysis and recursive partitioning analysis (RPA) identified predictors of survival and gastrostomy tube presence. Results. Multivariable analysis identified that HPV negativity (p = .0002), presence of extranodal extension (p = .0025), and advanced T classification (p = .0081) were independent predictors of survival. For HPV-positive patients, surgical approach (p = .0111) and margin status (p = .0287) were significant predictors of survival. For HPV-negative patients, extranodal extension (p = .0021) and advanced T classification (p = .0342) were significant predictors of survival. Smoking status and advanced neck disease did not impact survival, and the addition of adjuvant chemotherapy did not confer survival benefit in HPV-positive or HPV-negative subgroups. Conclusion. Independent predictors of survival are unique in patients with oropharyngeal SCC treated with primary surgery. (C) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:E1794 / E1802
页数:9
相关论文
共 41 条
  • [11] Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: A Phase II trial of the Radiation Therapy Oncology Group (RTOG 99-14)
    Garden, Adam S.
    Harris, Jonathan
    Trotti, Andy
    Jones, Christopher U.
    Carrascosa, Luis
    Cheng, Jonathan D.
    Spencer, Sharon S.
    Forastiere, Arlene
    Weber, Randal S.
    Ang, K. Kian
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (05): : 1351 - 1355
  • [12] Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers
    Gillison, Maura L.
    D'Souza, Gypsyamber
    Westra, William
    Sugar, Elizabeth
    Xiao, Weihong
    Begum, Shahnaz
    Viscidi, Raphael
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (06): : 407 - 420
  • [13] Swallowing dysfunction is a common sequelae after chemoradiation for oropharynx carcinoma
    Greven, Kathryn M.
    White, Douglas R.
    Browne, J. Dale
    Williams, Daniel W., III
    McGuirt, W. Fred, Sr.
    DAgostino, Ralph B., Jr.
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (03): : 209 - 212
  • [14] Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas
    Hafkamp, Harriet C.
    Manni, J. J.
    Haesvoets, A.
    Voogd, A. C.
    Schepers, M.
    Bot, F. J.
    Hopman, A. H. N.
    Ramaekers, F. C. S.
    Speel, Ernst-Jan M.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (12) : 2656 - 2664
  • [15] Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer
    Haughey, Bruce H.
    Sinha, Parul
    [J]. LARYNGOSCOPE, 2012, 122 : S13 - S33
  • [16] Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma - The University of California-San Francisco experience
    Huang, Kim
    Xia, Ping
    Chuang, Cynthia
    Weinberg, Vivian
    Glastonbury, Christine M.
    Eisele, David W.
    Lee, Nancy Y.
    Yom, Sue S.
    Phillips, Theodore L.
    Quivey, Jeanne M.
    [J]. CANCER, 2008, 113 (03) : 497 - 507
  • [17] Outcomes of Transoral Robotic Surgery: A Preliminary Clinical Experience
    Hurtuk, Agnes
    Agrawal, Amit
    Old, Matthew
    Teknos, Theodoros N.
    Ozer, Enver
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2011, 145 (02) : 248 - 253
  • [18] Quality-of-Life Outcomes in Transoral Robotic Surgery
    Hurtuk, Agnes M.
    Marcinow, Anna
    Agrawal, Amit
    Old, Matthew
    Teknos, Theodoros N.
    Ozer, Enver
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2012, 146 (01) : 68 - 73
  • [19] High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma
    Licitra, Lisa
    Perrone, Federica
    Bossi, Paolo
    Suardi, Simona
    Mariani, Luigi
    Artusi, Raffaella
    Oggionni, Maria
    Rossini, Chiara
    Cantu, Giulio
    Squadrelli, Massimo
    Quattrone, Pasquale
    Locati, Laura D.
    Bergamini, Cristiana
    Olmi, Patrizia
    Pierotti, Marco A.
    Pilotti, Silvana
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (36) : 5630 - 5636
  • [20] Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis
    Machtay, Mitchell
    Moughan, Jennifer
    Trotti, Andrew
    Garden, Adam S.
    Weber, Randal S.
    Cooper, Jay S.
    Forastiere, Arlene
    Ang, K. Kian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) : 3582 - 3589